Table: Garna Biosciences -Q1 group results

Carna Biosciences

08/05/2026 08:01

May 8 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2026        Mar 31, 2025       Dec 31, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            183 mln             143 mln           720 mln     
                 (+28.1 pct)         (-20.7 pct)       (+24.4 pct)   
  Operating     loss 458 mln        loss 497 mln        loss 2.03    
  Recurring     loss 488 mln        loss 498 mln        loss 2.05    
  Net           loss 513 mln        loss 499 mln        loss 2.09    
  EPS          loss 26.78 yen      loss 26.13 yen    loss 108.95 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T